MedPath

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

Not Applicable
Recruiting
Conditions
Stroke
Registration Number
NCT04187131
Lead Sponsor
University of Pittsburgh
Brief Summary

The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • ages18 and older
  • acute stroke
  • admitted to inpatient rehabilitation
  • presence of neglect (Behavioral Inattention Test total score <129, or scoring below pre-defined cutoff score in at least one of the six subtests)
  • more than 10/% missed targets on the Augmented Reality Screening Test
  • intact vibration (positive test on Vibration Sensation Test)
  • intact auditory function (positive test on Auditory Sensation Test)
  • English speaking
Exclusion Criteria
  • inability to follow one-step directions at least 80% of the time
  • current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor
  • metal in the head that causes interference with the EEG system
  • self-report of previous positive photic stimulation test

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Accuracy; indicated by percent agreement between participant report and EEG-based assessment of neglectweek 4

number of sessions attaining greater than 70 percentage agreement between targets identified by the participant and targets identified by EEG; participants view an augmented reality screen with randomly appearing targets in the field of view; when a target is viewed, the participant presses a keyboard key; immediately after, targets randomly appear on the augmented reality screen while the participant's brain activity is recorded by EEG; EEG detects viewed and neglected targets based on brain signals;

Reliability; indicated by correlation coefficient between two consecutive sessions of EEG recordingweek 4

number of consecutive sessions attaining Pearson correlation coefficient r greater than.10

Secondary Outcome Measures
NameTimeMethod
Program Satisfaction; indicated by mean score of 3 or greater on the Client Satisfaction Questionnaireweek 4

number of participants attaining greater than or equal to 90 percentage satisfaction; satisfaction is rated on 8 items with a 4-point likert scale, 4 indicating very high satisfaction; items are summed with total a total score of 32 indicating very high satisfaction;

Technology Satisfaction; indicated by a mean score of 3 or higher on the Quebec User Evaluation of Satisfaction with Assistive Technologyweek 4

number of participants attaining greater than or equal to 90 percentage satisfaction; satisfaction is rated on 12 items with a 5-point likert scale, 5 indicating very high satisfaction; items are summed with total a total score of 60 indicating very high satisfaction;

Trial Locations

Locations (2)

Northeastern University

🇺🇸

Boston, Massachusetts, United States

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

Northeastern University
🇺🇸Boston, Massachusetts, United States
Sarah Ostadabbas, PhD
Contact
617-373-4992
ostadabbas@ece.neu.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.